Denial of prescription pain medication among people who use drugs in Vancouver, Canada

Abstract Background People who use drugs experience pain at two to three times the rate of the general population and yet continue to face substantial barriers to accessing appropriate and adequate treatment for pain. In light of the overdose crisis and revised opioid prescribing guidelines, we soug...

Full description

Bibliographic Details
Main Authors: Evelyne Marie Piret, M.-J. Milloy, Pauline Voon, JinCheol Choi, Kora DeBeck, Kanna Hayashi, Thomas Kerr
Format: Article
Language:English
Published: BMC 2024-03-01
Series:Harm Reduction Journal
Subjects:
Online Access:https://doi.org/10.1186/s12954-024-00956-5
_version_ 1797233693885988864
author Evelyne Marie Piret
M.-J. Milloy
Pauline Voon
JinCheol Choi
Kora DeBeck
Kanna Hayashi
Thomas Kerr
author_facet Evelyne Marie Piret
M.-J. Milloy
Pauline Voon
JinCheol Choi
Kora DeBeck
Kanna Hayashi
Thomas Kerr
author_sort Evelyne Marie Piret
collection DOAJ
description Abstract Background People who use drugs experience pain at two to three times the rate of the general population and yet continue to face substantial barriers to accessing appropriate and adequate treatment for pain. In light of the overdose crisis and revised opioid prescribing guidelines, we sought to identify factors associated with being denied pain medication and longitudinally investigate denial rates among people who use drugs. Methods We used multivariable generalized estimating equations analyses to investigate factors associated with being denied pain medication among people who use drugs reporting pain in three prospective cohort studies in Vancouver, Canada. Analyses were restricted to study periods in which participants requested a prescription for pain from a healthcare provider. Descriptive statistics detail denial rates and actions taken by participants after being denied. Results Among 1168 participants who requested a prescription for pain between December 2012 and March 2020, the median age was 47 years and 63.0% were male. Among 4,179 six-month observation periods, 907 (21.7%) included a report of being denied requested pain medication. In multivariable analyses, age was negatively associated with prescription denial (adjusted odds ratio [AOR] = 0.98, 95% confidence interval [CI]:0.97–0.99), while self-managing pain (AOR = 2.48, 95%CI:2.04–3.00), experiencing a non-fatal overdose (AOR = 1.51, 95%CI:1.22–1.88), engagement in opioid agonist therapy (AOR = 1.32, 95%CI:1.09–1.61), and daily use of heroin or other unregulated opioids (AOR = 1.32, 95%CI:1.05–1.66) were positively associated with being denied. Common actions taken (n = 895) after denial were accessing the unregulated drug supply (53.5%), doing nothing (30.6%), and going to a different doctor/emergency room (6.1%). The period following the introduction of new prescribing guidelines was not associated with a change in denial rates. Conclusions A substantial proportion of people who use drugs continue to be denied prescriptions for pain, with such denial associated with important substance use-related harms, including non-fatal overdose. Guidelines specific to the pharmaceutical management of pain among people who use drugs are needed.
first_indexed 2024-04-24T16:20:14Z
format Article
id doaj.art-b925953d45544827a2d79140422207a3
institution Directory Open Access Journal
issn 1477-7517
language English
last_indexed 2024-04-24T16:20:14Z
publishDate 2024-03-01
publisher BMC
record_format Article
series Harm Reduction Journal
spelling doaj.art-b925953d45544827a2d79140422207a32024-03-31T11:14:21ZengBMCHarm Reduction Journal1477-75172024-03-0121111310.1186/s12954-024-00956-5Denial of prescription pain medication among people who use drugs in Vancouver, CanadaEvelyne Marie Piret0M.-J. Milloy1Pauline Voon2JinCheol Choi3Kora DeBeck4Kanna Hayashi5Thomas Kerr6British Columbia Centre On Substance UseBritish Columbia Centre On Substance UseBritish Columbia Centre On Substance UseBritish Columbia Centre On Substance UseBritish Columbia Centre On Substance UseBritish Columbia Centre On Substance UseBritish Columbia Centre On Substance UseAbstract Background People who use drugs experience pain at two to three times the rate of the general population and yet continue to face substantial barriers to accessing appropriate and adequate treatment for pain. In light of the overdose crisis and revised opioid prescribing guidelines, we sought to identify factors associated with being denied pain medication and longitudinally investigate denial rates among people who use drugs. Methods We used multivariable generalized estimating equations analyses to investigate factors associated with being denied pain medication among people who use drugs reporting pain in three prospective cohort studies in Vancouver, Canada. Analyses were restricted to study periods in which participants requested a prescription for pain from a healthcare provider. Descriptive statistics detail denial rates and actions taken by participants after being denied. Results Among 1168 participants who requested a prescription for pain between December 2012 and March 2020, the median age was 47 years and 63.0% were male. Among 4,179 six-month observation periods, 907 (21.7%) included a report of being denied requested pain medication. In multivariable analyses, age was negatively associated with prescription denial (adjusted odds ratio [AOR] = 0.98, 95% confidence interval [CI]:0.97–0.99), while self-managing pain (AOR = 2.48, 95%CI:2.04–3.00), experiencing a non-fatal overdose (AOR = 1.51, 95%CI:1.22–1.88), engagement in opioid agonist therapy (AOR = 1.32, 95%CI:1.09–1.61), and daily use of heroin or other unregulated opioids (AOR = 1.32, 95%CI:1.05–1.66) were positively associated with being denied. Common actions taken (n = 895) after denial were accessing the unregulated drug supply (53.5%), doing nothing (30.6%), and going to a different doctor/emergency room (6.1%). The period following the introduction of new prescribing guidelines was not associated with a change in denial rates. Conclusions A substantial proportion of people who use drugs continue to be denied prescriptions for pain, with such denial associated with important substance use-related harms, including non-fatal overdose. Guidelines specific to the pharmaceutical management of pain among people who use drugs are needed.https://doi.org/10.1186/s12954-024-00956-5PainPain managementPrescription denialPeople who use drugsPrescribing guidelines
spellingShingle Evelyne Marie Piret
M.-J. Milloy
Pauline Voon
JinCheol Choi
Kora DeBeck
Kanna Hayashi
Thomas Kerr
Denial of prescription pain medication among people who use drugs in Vancouver, Canada
Harm Reduction Journal
Pain
Pain management
Prescription denial
People who use drugs
Prescribing guidelines
title Denial of prescription pain medication among people who use drugs in Vancouver, Canada
title_full Denial of prescription pain medication among people who use drugs in Vancouver, Canada
title_fullStr Denial of prescription pain medication among people who use drugs in Vancouver, Canada
title_full_unstemmed Denial of prescription pain medication among people who use drugs in Vancouver, Canada
title_short Denial of prescription pain medication among people who use drugs in Vancouver, Canada
title_sort denial of prescription pain medication among people who use drugs in vancouver canada
topic Pain
Pain management
Prescription denial
People who use drugs
Prescribing guidelines
url https://doi.org/10.1186/s12954-024-00956-5
work_keys_str_mv AT evelynemariepiret denialofprescriptionpainmedicationamongpeoplewhousedrugsinvancouvercanada
AT mjmilloy denialofprescriptionpainmedicationamongpeoplewhousedrugsinvancouvercanada
AT paulinevoon denialofprescriptionpainmedicationamongpeoplewhousedrugsinvancouvercanada
AT jincheolchoi denialofprescriptionpainmedicationamongpeoplewhousedrugsinvancouvercanada
AT koradebeck denialofprescriptionpainmedicationamongpeoplewhousedrugsinvancouvercanada
AT kannahayashi denialofprescriptionpainmedicationamongpeoplewhousedrugsinvancouvercanada
AT thomaskerr denialofprescriptionpainmedicationamongpeoplewhousedrugsinvancouvercanada